Laura De Nardi
Maria Andrea Lanzetta
Elena Ghirigato1
Egidio Barbi- 1University of Trieste, Clinical Department of Medical Surgical and Health Science, Trieste, Italy
- 2Department of Pediatrics, Institute for Maternal and Child Health IRCCS “Burlo Garofolo”, Trieste, Italy
Background: Fatigue is a common, nonspecific complaint commonly used to describe various conditions, ranging from a vague, subjective sense of weariness to muscular weakness, fatigability, exercise intolerance or excessive daytime somnolence. Despite its high frequency in the general population, literature addressing the approach to the child with fatigue from a general pediatrician perspective is poor. We herein propose a review of the available evidence on the topic, providing a practical framework to assist physicians in dealing with the issue.
Methods: Data were identified by searches of MEDLINE, UpToDate, Google Scholar and references from relevant articles. Articles published between 1990 and 2021 were considered, prioritizing systematic reviews and meta-analyses. Then, an empirically-based model of approaching the tired child was proposed according to our center experience.
Results: To correctly characterize the meaning of fatigue reporting, specific clues from history and physical examination should be emphasized. Duration, severity, and the age at onset are to be considered. Then, specific queries about everyday activities, sleep hygiene and social domain could be useful in reaching a specific diagnosis and offering an appropriate treatment.
Conclusions: We suggest a pragmatic approach to fatigue in children based on age assessment, targeted questions, physical examination clues, and some laboratory first-level tests. This could provide pediatricians with a useful tool to discriminate the broad etiology of such a complaint, disentangling between psychological and organic causes. Further studies are needed to investigate the predictive value, specificity and sensitivity of this diagnostic workflow in managing the child with fatigue.
Introduction
Tiredness, weariness, weakness, fatigability and fatigue are words commonly used in the everyday vocabulary, sometimes mistakenly as synonyms, to describe a sense of difficulty or inability to initiate, maintain or complete tasks which require mental and/or physical energy. However, such different meanings should not be interchangeable to the physician. For example, the reduced capacity to maintain an activity, defined as easy fatigability and evocative of a myasthenic syndrome, should be distinguished from the inability to initiate or perform a specific action, which may underlie a neurological or muscular disease. Also, discriminating between psychological and physical tiredness can be challenging, especially among adolescent patients. Furthermore, fatigue can be secondary to an almost unlimited range of acute and chronic diseases encompassing cardiological, pulmonary, endocrinological, gastrointestinal, nephrological, rheumatological and metabolic conditions, cancer, and psychological/psychiatric comorbidities (1–7).
Due to the broad etiology and subjectivity of its reports, the epidemiology of fatigue is also rather challenging to define. A generic complaint of fatigue represents about 10%–15% of primary care consultations among adults (8). Notably, in adults, chronic fatigue is strongly associated with psychiatric disorders, with two-thirds of people suffering from long-lasting fatigue being also affected by psychiatric comorbidities (9). The prevalence of children complaining of fatigue falls to about 4.4%, depending on sex and age, with the highest frequency amongst adolescent females (10, 11). Remarkably, the reported number of pediatric patients complaining of psychological fragility has continuously been increasing in the last decades (12–14). Recent studies found fatigue to be more prevalent in children affected by chronic diseases, reaching a rate of 21.2% in those with cystic fibrosis, autoimmune diseases and post-cancer treatment, and 25% in pediatric rheumatic disease (15, 16). The available literature has mainly focused on quantifying and managing fatigue in the broader context of childhood chronic diseases (3–6, 17), while less is written on the definition and categorization of fatigue complaint per se. Another significant proportion of studies deals with chronic fatigue syndrome (CFS), a blurred defined and debated clinical entity, with specific diagnostic criteria and significant overlap with psychiatric and functional disorders (18, 19).
Due to the inherent subjectivity of the symptom, quantification and assessment of fatigue is even more challenging in the pediatric population for the possible ambivalence between patient's and parental reports (20). Physicians, in their daily practice, use age criteria, history and physical examination clues to discriminate the different hypotheses and establish if and which tests are to be performed. However, despite the high frequency of such a complaint, we are not aware of any study or review suggesting a general pediatric guideline in this perspective. Applying a diagnostic algorithm to the symptom of fatigue could help to discriminate its multiple causes, possibly leading, on the one hand, to an early diagnosis of specific organic conditions and, on the other, to the timely unmasking of possible mental health problems. The latter is especially relevant, as symptom persistence is reported to lead to prolonged school absence, isolation and loss of activities resulting in the risk of academic failure and development of psychiatric conditions in adult age (21–23). This work aims to review the available evidence on the topic and provide a pragmatic framework to assist the pediatrician in dealing with the child complaining of fatigue as the main isolated symptom, both in primary care setting and in the emergency department. Further studies will be needed to assess the effectiveness of this approach and improve it.
Materials and methods
Data were identified by searches of MEDLINE, UpToDate, Google Scholar and references from relevant articles. The following search string was used for MEDLINE: (“fatigue” OR “weakness” OR “tiredness” OR “weariness” OR “drowsiness”) AND (“child” OR “pediatric” OR “paediatric” OR “children” OR “kid” OR “toddler”). We also combined the keywords “tired child”, “child with fatigue”, “paediatric fatigue”, “pediatric fatigability”, (“chronic fatigue” AND “children”), (“medication” OR “drugs” AND “fatigue” AND “children”), (“sleep disturbances” AND “children”) for the all databases.
Over 2000 articles were initially found through this search strategy, which included articles published between 1990 and 2021 in English and other languages, provided that an English abstract was available. With the aim of providing a practical decision-making strategy, we focused on articles dealing with fatigue as the main and isolated generic complaint, excluding papers related to fatigue in the context of already known chronic diseases, and fatigue related to Coronavirus disease (COVID-19). We prioritized systematic reviews and meta-analyses, and peer-reviewed literature in the public domain. We also included clinical and narrative review articles to provide more details on the topic to the readers. Only two not English articles were included and translated by native speakers. The examination of the literature was mostly focused on the pediatric population. However, when considering broader concepts applicable to both pediatric and adult patients, such as pathophysiology of fatigue and medication side-effects, the search was not restricted solely to pediatric literature. After the exclusion of duplicates, case reports and small case series, we restricted the results to 77 papers. Search strategy and literature results are synthetized in Table S1 and S2 (see Supplementary file S1).
Then, an empirically-based model of approaching the tired child was proposed according to our center experience and optimized with input from literature evidences. Since our literature search did not retrieve any previous attempt to establish a similar decision-making tool, we drew some information about fatigue assessment and useful lab tests from Guidelines on Chronic Fatigue Syndrome (24–27). Indeed, the CSF diagnosis requires the exclusion of all the other possible causes of fatigue, and some anamnestic elements, red flags and lab tests reported in our algorithm are the same included in the CSF diagnostic workout, which have a level of evidence D according to Delphi consensus (24). Besides that, other two works we considered very useful in the creation of such a perspective paper were drawn from UpToDate (28,29). We then integrated this information with our pediatric experience.
Classification and pathophysiology of fatigue
Fatigue may be physiological or pathological. Brief periods of fatigue, occurring in approximately 15%–25% of the general population, can be secondary to situational stressors with an identifiable cause, such as physical exercise, acute febrile or flu-like illness, mental stress, or sleep deprivation (30, 31). In contrast to physiological fatigue, which is self-limited and rapidly resolved by treating the underlying factors, pathologic fatigue can be prolonged (lasting one to five months) or chronic (lasting six months or longer). Perception and performance are the two primary domains that contribute to fatigue classification. Indeed, it can be mental (due to a subjective sense of perceived fatigue) or physical (as an objective and measurable phenomenon) (32). Homeostatic and psychological factors can influence mental fatigue. Potential homeostatic contributors to the perception of fatigue include energetic, inflammatory, and neural feedback such as glycogen depletion, increased brain temperature, accumulation of ammonia, inflammatory cytokines, increases in serotonin, and decrements in dopamine among hypothalamic networks. Psychological factors include attitude, motivational influences, endurance, resilience, expectations, concentration, intention and mood. These aspects can be affected by psychiatric diseases such as depression, psychosis, addiction or burnout syndrome manifesting with a fatigue complaint (32–34). Physical fatigue, on the other hand, can be secondary to neurological or non-neurological disorders. When considering neurological causes of fatigue, they can be due to central or peripheral mechanisms (35). Central neurological fatigue depends on a progressive decline in voluntary activation of muscles; it may result from dysfunction of specific cortical or subcortical networks and may be due to spinal or supraspinal disfunction (31, 33, 34). The mechanism at the base of central fatigue disorders may depend on increased inhibitory interneuron input to the motor cortex, delayed central conduction from a demyelination process, poor coordination of motor unit firing and increased negative feedback from muscle afferent sensory neurons, or impaired recruitment of motor units (33). Examples of diseases characterized by central fatigue are multiple sclerosis, cerebrovascular ischemia, mitochondrial disorders, hereditary spastic paraplegias, spinocerebellar ataxias, central nervous system (CNS) infections and tumors, and traumatic brain injury. Central neurological fatigue can sometimes overlap with the previously mentioned mental fatigue. A motivational input actually activates a facilitation system to increase motor output from the primary motor cortex to overcome supraspinal fatigue and the sensory inhibition system from the peripheral system.
Peripheral fatigue is usually secondary to second motor neuron dysfunction, peripheral nerves, neuromuscular junction, or muscular diseases. The responsible mechanisms include axonal loss, demyelination process, or conduction block. In contrast, muscular mechanisms include loss of electrical conduction along the muscle membrane to the T-tubule system, impaired calcium release from the sarcoplasmic reticulum, altered interaction between actin and myosin, reduced calcium reuptake, and altered oxidative phosphorylation or glycolysis processes (33). Diseases that may present with peripheral neurological fatigue include second motor neuron dysfunctions, polyradiculopathies, plexopathies, polyneuropathies, neuromuscular transmission diseases, myopathies, or rhabdomyolysis (31, 36). Muscle weakness may be secondary to accumulation of intracellular lactate and hydrogen ions with consequent acidosis, depletion of glycogen, ATP, phosphocreatine, calcium conductance changes, and reactive oxidative species (ROS) (31).
These mechanisms are, for example, involved in glycogen storage disorders or mitochondrial myopathies. Finally, neurological fatigue may subtend at least two distinct subtypes that can coexist and should be sought: easy fatigability and true muscle weakness. The former is defined by the incapability to maintain muscle strength for prolonged periods of time and is typical of neuromuscular junction disease (i.e., myasthenia gravis). The latter, presenting as a partial or complete loss of muscle strength needed to start an activity, may be associated with muscle hypertonia and hyperreflexia in first motoneuron diseases, or with muscle hypotonia, hypotrophy, hyporeflexia with or without fasciculations in second motor neuron diseases and myopathies (see Table S3, Supplementary file S2).
Non-neurological diseases, instead, can cause fatigue through some of the mechanisms previously reported as pathogenetic of mental fatigue: pro-inflammatory cytokines, anemia, hormone deficiencies, poor nutrition, vitamin deficiencies, toxins, and poor tissue perfusion (37). These phenomena may be triggered by infectious, hematologic, gastroenterological (celiac disease, Chron disease), rheumatological, and endocrine disorders (diabetes, Addison's disease, hypothyroidism, hypopituitarism), as well as malignancies, and heart or kidney failure. In these cases, fatigue is rarely an isolated complaint, and the presence of one or more other symptoms will help with the diagnosis. One further possible cause is drug-related fatigue (38). For some medications, such as benzodiazepines, antiepileptics, neuroleptic and selected anti-hypertensives, drug-related fatigue is an on-target side effect (39–41). When considering old generation anti-histamines or non-selective beta-blockers instead, fatigue and sedation are off-target side effects due to, in the former case, to binding of H1 receptors in the CNS, and in the latter case, to alpha-blockade activity (41, 42). Amongst benzodiazepines, fatigue has been described (15%–30%) with clonazepam, clobazam, lorazepam and diazepam. When considering anti-epileptics, fatigue is most common with phenobarbital, primidone, vigabatrin, gabapentin and levetiracetam (40). Amongst anti-hypertensives, instead, sedation has been described as an adverse effect of clonidine and labetalol (43). Sedation is quite common also with second-generation antihistamine drugs, especially cetirizine, which is widely used in the pediatric population (44).
The diagnostic workflow
Figure 1 summarizes a proposal of a decision-making algorithm.
Figure 1. Proposal of a diagnostic flowchart to assess the child complaining of fatigue. Abbreviations: ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; TSH, thyroid-stimulating hormone; TTG, tissue transglutaminase; AST, aspartate transaminase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; CPK, creatine phosphokinase; ECG, electrocardiogram; ENT, ear nose and throat; SSD, somatic symptom disorder.
Consider fatigue duration and severity
An isolated unspecific sensation of mild to moderate fatigue lasting less than one month, without any history or physical examination red flags, should be deferred for further evaluation at a later follow-up, as in the majority of the cases, it is self-resolving (45). It is the most common complaint to the general pediatrician and may be related to subclinical viral infection or temporary alterations in habits and environmental conditions, such as stress due to school or other extra-curricular activities.
Age matters
Age is a crucial element to consider. Adolescence per se represents a delicate and complex moment in life, marked by increased self-identity and growing independence but also by higher sensitivity to adults' expectations, school performance and competition with peers (46). Adaptation to such stressors requires resilience, which depends on the presence of a healthy group of peers and personal coping strategies. However, when these are lacking, the resulting sense of inadequacy can predispose to somatic symptom disorders (SSDs) or psychiatric comorbidities (i.e., anxiety and depression), which can arise with a subjective sense of fatigue (47, 10). Therefore, SSD and other psychological conditions should be kept high in the list of differential diagnoses of adolescents or older children complaining of fatigue. On the other hand, organic causes must be considered the most prevalent in pre-scholar patients (48).
Differentiate the types of fatigue through key questions
Different conditions with specific characteristics and definitions may be confused with or described as “fatigue”: muscle weakness, easy fatigability, exercise intolerance and excessive daytime sleepiness (Table S4, Supplementary file S2). They should be addressed and distinguished through specific questions. Finally, the psychological domain should be explored. We, thus, propose some key queries to ask the child complaining of fatigue as part of the diagnostic workflow (Figure 1).
Firstly, the presence of muscle weakness should be investigated and further characterized through the following question: “Is there any difficulty climbing the stairs or combing hair?”. Indeed, the incapability of performing such activities, involving the pelvic and shoulder girdle, is suggestive of proximal muscle weakness and should lead the diagnosis towards myopathies or a Guillain Barré syndrome. A thorough neurological examination should always be performed and focused on detecting proximal or distal hyposthenia, as well as manifestations of the first or second motor-neuron syndrome, such as spasticity or alteration of deep tendon reflexes, respectively with hyper or hyporeflexia (49, 50).
As a second question, we propose: “Is there progressive exhaustibility during an exercise or in the course of the day?”. This query highlights easy fatigability, a possible hallmark of myasthenia gravis and polymyositis.
In third place, exercise intolerance should be investigated through questions like: “Is there any difficulty attending gym class or doing physical exercise?” and “Do you need to stop soon after having started running or playing a game?” or “Do you usually vomit after playing games?”. Exercise intolerance, which can be thus detected, can be due to alteration of cardiovascular, pulmonary and muscular function or to mitochondrial diseases (51, 52).
Moreover, excessive daytime drowsiness should be addressed by a question about sleep habits and quality. Excessive somnolence has different causes based on the patient's age. During the first months of life, it can be a sign of worsening muscle hypotonia or an underlying metabolic disorder (53). During adolescence, daytime sleepiness is often related to poor sleep hygiene and associated with mental health issues (54, 55). On the contrary, younger children with obstructive sleep apnea syndrome, who lack quantity or quality of sleep, usually present with hyperactive behavior and concentration difficulties (56). Therefore, at this age, when daytime drowsiness is present, it should point toward an organic cause of poor sleep. Lastly, uncontrolled allergic rhinitis, asthma and atopic dermatitis are also known to affect sleep patterns, and should thus be considered in the differential diagnosis of a tired child (57–59).
Furthermore, a specific question addressing drugs being taken is imperative. A thorough medication history must be gathered, with particular focus on drugs which are known to cause fatigue and sedation: benzodiazepines, neuroleptics, anti-hypertensives, antiepileptics and anti-histamines.
Finally, it is mandatory to assess the social and psychological domain: “Do you regularly attend school?”, “Did you recently interrupt previously regular after-school activities?”, “Do you have a peer group of friends?”, “Do you spend many hours alone in your room using electronic devices?”. Any positive answer should direct clinicians toward psychological domain impairment and functional disorders, especially if the age is consistent and the patient is an adolescent. School absenteeism, the lack of a group of peers and excessive time spent on electronic media are some of the predominantly recognized markers of children's mental health-related problems, including depression and SSD (60–63). In addition, physical inactivity, sleep alterations and somatic symptoms have been found to predict the development of severe and persistent fatigue in children, further confirming a significant overlap between chronic fatigue and somatic symptom disorders (64). Remarkably, physicians should be aware that SSD can frequently develop in children with a pre-existing chronic illness; when confirmed, it should be addressed and treated through implementation of specific psycho-social measures.
Consider history and accompanying clinical signs
Fever, night sweats, itching, vomit, diarrhea, weight loss, growth impairment, musculoskeletal pain, joint limitation, or pain can help orient the diagnosis towards a more focused gastrointestinal, oncologic or rheumatological disease field. Worsening school performance may be among the first signs of impaired thyroid function. History elements, clinical signs and red flags to search for in order to rule out the main severe underlying etiologies of fatigue are summarized in Table 1. In their absence, the pediatrician could tend towards a “watchful waiting” approach, with re-evaluation of the child over time.
Table 1. Red flags to search for in a child complaining of fatigue. Abbreviations: IBD, intestinal bowel disease; SSD, somatic symptom disorder; SMA, spinal muscular atrophy.
Perform a panel of first level blood tests
Figure 1 shows the panel of first-level blood tests that should always be performed on the child complaining of fatigue. When the first-level tests show any alteration, or if they are unremarkable but signs and symptoms are consistent with a specific clinical diagnosis, physicians should go ahead in the diagnostic evaluation, performing second-level tests (Table S5, see Supplementary file S2). However, astute clinicians should always use them appropriately and judiciously, in order to avoid over-medicalization. Remarkably, literature on both adult and pediatric patients advises against performing serologies for cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Lyme disease because hardly any finding could affect the clinical behavior, and results could be confounding (65). On the other hand, in front of suggestive associated symptoms or if the patient is from a place with high endemicity, QuantiFERON or Mantoux test to exclude tuberculosis should be performed.
Dealing with chronic fatigue syndrome
Once all the possible organic causes at the base of fatigue have been excluded, the literature suggests considering the diagnosis of Chronic Fatigue Syndrome (CFS), a condition also known as myalgic encephalomyelitis, with uncertain etiology and a reported prevalence of 1%–2% in children and adolescents (11). The pediatric diagnostic criteria are less well-defined than adults' ones. Guidelines vary slightly among different groups (24, 25, 66, 67). However, they mostly agree on some key differences compared to the adult guidelines. In particular, the diagnosis of pediatric CFS should be considered when symptoms persist for more than three months (compared to six in the adult population), symptom onset must be gradual, and a debilitating and chronic sense of fatigue should be associated with post-exertional malaise, pain, dizziness, alterations in sleep and decreased neurocognitive performance. Furthermore, all authors include elements to distinguish CFS from “school phobia” (27). Indeed, one of the main issues plaguing children diagnosed with CFS is school absenteeism (68), associated with a severe decrease in general functioning, with some patients even becoming bed-ridden or wheelchair-bound (69). These features suggest an overlap between CFS, SSD, and psychiatric populations. One-third of adolescents diagnosed with CFS are actually affected by mental health problems (70), presenting higher rates of emotional distress, “internalizing” symptoms (mainly anxiety and depression) and personality disorders (71). This overlap is further supported by the fact that SSDs and CFS are more common in female adolescents than males (24). A somatic or psychological rather than organic origin of CFS appears to be likely, considering that the most effective therapeutic intervention was found to be cognitive behavioral therapy (72).
From a pragmatic perspective, we suggest that CFS should be an exclusion diagnosis well before the three months needed to formalize it. Notably, strong consideration should be given to the presence of an underlying SSD, a condition much more prevalent than CFS in the pediatric population (10%–15%) (73–75). A recognized fact is that doctors are often uncomfortable diagnosing SSDs; hence patients with functional disorders are frequently misdiagnosed as having some medically unexplained syndrome (76) or some blurred clinical entity that can be identified on a case-by-case basis within CFS, fibromyalgia, or chronic Lyme disease (77–79). This issue becomes relevant in pediatrics for the associated risks of perpetuating over-medicalization (80) and over-diagnosing the above-cited conditions (81).
Conclusions
This paper suggests a pragmatic approach to fatigue in children based on age assessment, targeted questions, physical examination clues, and a few laboratory first-level tests. The main limit of this work is that such a clinical algorithm has not been validated on a large population. However, we tried to provide a perspective on the topic offering a succinct and practical method to address a very broad issue. Further studies are needed to investigate the predictive value, specificity and sensitivity of specific diagnostic workflows in managing the child with fatigue.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.
Author contributions
GG is responsible for the conception of the work. LD, ML and EG wrote the first draft of the manuscript. GG and EB critically revised the article for relevant intellectual content. LD prepared figures and tables. All the authors reviewed the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the Ministry of Health, Rome - Italy, in collaboration with the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste – Italy. RC 34/18.
Acknowledgments
The authors thank Martina Bradaschia for the English revision of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fped.2022.1044170/full#supplementary-material.
Abbreviations
CFS, chronic fatigue syndrome; CMV, cytomegalovirus; CNS, central nervous system; EBV, epstein-barr virus; ROS, reactive oxidative species; SSD, somatic symptom disorders
References
1. Sun R, Liu M, Lu L, Zheng Y, Zhang P. Congenital heart disease: causes, diagnosis, symptoms, and treatments. Cell Biochem Biophys. (2015) 72(3):857–60. doi: 10.1007/s12013-015-0551-6
2. Nap-van der Vlist MM, Burghard M, Hulzebos HJ, Doeleman WR, Heijerman HGM, van der Ent CK, et al. Prevalence of severe fatigue among adults with cystic fibrosis: a single center study. J Cyst Fibros. (2018) 17(3):368–74. doi: 10.1016/j.jcf.2018.03.003
3. Varni JW, Limbers CA, Bryant WP, Wilson DP. The PedsQL multidimensional fatigue scale in type 1 diabetes: feasibility, reliability, and validity. Pediatr Diabetes. (2009) 10(5):321–8. doi: 10.1111/j.1399-5448.2008.00482.x
4. Van de Vijver E, Van Gils A, Beckers L, Van Driessche Y, Moes ND, van Rheenen PF. Fatigue in children and adolescents with inflammatory bowel disease. World J Gastroenterol. (2019) 25(5):632–43. doi: 10.3748/wjg.v25.i5.632
5. Houghton KM, Tucker LB, Potts JE, McKenzie DC. Fitness, fatigue, disease activity, and quality of life in pediatric lupus. Arthritis Rheum. (2008) 59(4):537–45. doi: 10.1002/art.23534
6. Van Dijk-Lokkart EM, Steur LMH, Braam KI, Veening MA, Huisman J, Takken T, et al. Longitudinal development of cancer-related fatigue and physical activity in childhood cancer patients. Pediatr Blood Cancer. (2019) 66(12):e27949. doi: 10.1002/pbc.27949
7. Garralda E, Rangel L, Levin M, Roberts H, Ukoumunne O. Psychiatric adjustment in adolescents with a history of chronic fatigue syndrome. J Am Acad Child Adolesc Psychiatry. (1999) 38(12):1515–21. doi: 10.1097/00004583-199912000-00012
9. Taylor RR, Jason LA, Jahn SC. Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample. Psychosom Med. (2003) 65(5):896–901. doi: 10.1097/01.psy.0000088580.28749.7f
10. Farmer A, Fowler T, Scourfield J, Thapar A. Prevalence of chronic disabling fatigue in children and adolescents. Br J Psychiatry. (2004) 184(6):477–81. doi: 10.1192/bjp.184.6.477
11. Haines LC. Prevalence of severe fatigue in primary care. Arch Dis Child. (2005) 90(4):367–8. doi: 10.1136/adc.2003.039917
12. Bignardi G, Dalmaijer ES, Anwyl-Irvine AL, Smith TA, Siugzdaite R, Uh S, et al. Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown. Arch Dis Child. (2020) 106(8):791–7. doi: 10.1136/archdischild-2020-320372
13. Taastrøm A, Klahn J, Staal N, Thomsen PH, Johansen A. Children and adolescents in the psychiatric emergency department: a 10-year survey in Copenhagen county. Nord J Psychiatry. (2014) 68(6):385–90. doi: 10.3109/08039488.2013.846410
14. Caqueo-Urízar A, Flores J, Escobar C, Urzúa A, Irarrázaval M. Psychiatric disorders in children and adolescents in a middle-income latin American country. BMC Psychiatry. (2020) 20(1):104. doi: 10.1186/s12888-020-02512-4
15. Nap-van der Vlist MM, Dalmeijer GW, Grootenhuis MA, van der Ent CK, van den Heuvel-Eibrink MM, Wulffraat NM, et al. Fatigue in childhood chronic disease. Arch Dis Child. (2019) 104(11):1090–5. doi: 10.1136/archdischild-2019-316782
16. Nijhof LN, van de Putte EM, Wulffraat NM, Nijhof SL. Prevalence of severe fatigue among adolescents with pediatric rheumatic diseases. Arthritis Care Res (Hoboken). (2016) 68(1):108–14. doi: 10.1002/acr.22710
17. Crichton A, Knight S, Oakley E, Babl FE, Anderson V. Fatigue in child chronic health conditions: a systematic review of assessment instruments. Pediatr. (2015) 135(4):e1015–31. doi: 10.1542/peds.2014-2440
18. Rollnik JD. Chronic fatigue syndrome: a critical review. Fortschr Neurol Psychiatr. (2017) 85(2):79–85. doi: 10.1055/s-0042-121259
19. Capelli E, Zola R, Lorusso L, Venturini L, Sardi F, Ricevuti G. Chronic fatigue syndrome/myalgic encephalomyelitis: an update. Int J Immunopathol Pharmacol. (2010) 23(4):981–9. doi: 10.1177/039463201002300402
20. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. (2001) 10(4):347–57. doi: 10.1023/a:1012253723272
21. Bell DS, Jordan K, Robinson M. Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome. Pediatr. (2001) 107(5):994–8. doi: 10.1542/peds.107.5.994
22. Sankey A, Hill CM, Brown J, Quinn L, Fletcher A. A follow-up study of chronic fatigue syndrome in children and adolescents: symptom persistence and school absenteeism. Clin Child Psychol Psychiatry. (2006) 11(1):126–38. doi: 10.1177/1359104506059133
23. Wilson A, Hickie I, Lloyd A, Hadzi-Pavlovic D, Boughton C, Dwyer J, et al. Longitudinal study of outcome of chronic fatigue syndrome. Br Med J. (1994) 308(6931):756–9. doi: 10.1136/bmj.308.6931.756
24. Evidence based guideline for the management of CFS/ME (chronic fatigue syndrome/myalgic encephalopathy) in children and young people. London: Royal College of Paediatrics and Child Health; 2004. Available at: https://www.whatdotheyknow.com/request/370385/response/925312/attach/5/Appendix%203%20RCPCH%20CFS.pdf [accessed 2022 June 21].
25. National Collaborating Centre for Primary Care (UK). Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy) in Adults and Children [Internet]. London: Royal College of General Practitioners (UK); 2007 [cited 2022 May 20]. (National Institute for Health and Clinical Excellence: Guidance). Available at: http://www.ncbi.nlm.nih.gov/books/NBK53577/[accessed 2022 June 21].
26. NICE (National Institute for Health and Care Excellence) guideline; Royal College of Physicians. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NG206). Published: 29 October 2021. Available at: www.nice.org.uk/guidance/ng206 [accessed 2022 June 21]
27. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US); 2015 Feb 10. 3, Current Case Definitions and Diagnostic Criteria, Terminology, and Symptom Constructs and Clusters. Available at: https://www.ncbi.nlm.nih.gov/books/NBK284898/[accessed 2022 June 21].
28. Fosnocht KM, Ende J. Approach to the adult patient with fatigue. In: Uptodate, Elmore JG and Givens J (Ed), UpToDate, Waltham, MA, 2022.
29. Shefner JM. Approach to the patient with muscle weakness. In: Uptodate, Targoff IN and Wilterdink JL (Ed), UpToDate, Waltham, MA, 2022.
30. Jason LA, Evans M, Brown M, Porter N. What is fatigue? Pathological and nonpathological fatigue. M&R. (2010) 2(5):327–31. doi: 10.1016/j.pmrj.2010.03.028
31. Tanaka M, Watanabe Y. Supraspinal regulation of physical fatigue. Neurosci Biobehav Rev. (2012) 36(1):727–34. doi: 10.1016/j.neubiorev.2011.10.004
32. Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurol. (2013) 80(4):409–16. doi: 10.1212/WNL.0b013e31827f07be
33. Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Med. (2014) 31(5):562–75. doi: 10.1177/1049909113494748
34. Davis MP, Walsh D. Mechanisms of fatigue. J Support Oncol. (2010) 8(4):164–74. PMID: 2082203420822034
35. Penner IK, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. (2007) 13(11):662–75. doi: 10.1038/nrneurol.2017.117
36. Janssens L, Brumagne S, McConnell AK, Raymaekers J, Goossenns N, Gayan-Ramirez G, et al. The assessment of inspiratory muscle fatigue in healthy individuals: a systematic review. Respir Med. (2013) 107(3):331–46. doi: 10.1016/j.rmed.2012.11.019
37. Dantzer R, Capuron L, Irwin MR, Miller AH, Ollat H, Perry VH, et al. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinol. (2008) 33(1):18–29. doi: 10.1016/j.psyneuen.2007.10.008
38. Murray BJ. Excessive daytime sleepiness due to medical disorders and medications. In: Uptodate, Scammel TE, Eichler AF (Ed), UpToDate, Waltham, MA, 2022.
39. Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. (2013) 13(2):214–23. PMID: 23789008; PMCID: PMC368433123789008
40. Siniscalchi A, Gallelli L, Russo E, De Sarro G. A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. Eur J Pharmacol. (2013) 718(1-3):10–6. doi: 10.1016/j.ejphar.2013.09.013
41. Ojha U, Ruddaraju S, Sabapathy N, Ravindran V, Woeapongsatitaya P, Haq J, et al. Current and emerging classes of pharmacological agents for the management of hypertension. Am J Cardiovasc Drugs. (2021) 22(3):271–85. doi: 10.1007/s40256-021-00510-9
42. Hu Y, Sieck DE, Hsu WH. Why are second-generation H1-antihistamines minimally sedating? Eur J Pharmacol. (2015) 765:100–6. doi: 10.1016/j.ejphar.2015.08.016
43. Jackson RE, Bellamy MC. Antihypertensive drugs. BJA Education. (2015) 15(6):280–5. doi: 10.1093/bjaceaccp/mku061
44. Recto MT, Gabriel MT, Kulthanan K, Tantilipikorn P, Chen-Wee Aw D, Lee TH, et al. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clin Mol Allergy. (2017) 15:1. doi: 10.1186/s12948-017-0074-3
45. Wolbeek M T, van Doornen LJP, Kavelaars A, Heijnen CJ. Severe fatigue in adolescents: a common phenomenon? Pediatr. (2006) 117(6):e1078–1086. doi: 10.1542/peds.2005-2575
46. Fegran L, Hall EOC, Uhrenfeldt L, Aagaard H, Ludvigsen MS. Adolescents’ and young adults’ transition experiences when transferring from paediatric to adult care: a qualitative metasynthesis. Int J Nurs Stud. (2014) 51(1):123–35. doi: 10.1016/j.ijnurstu.2013.02.001
47. Liao SC, Ma HM, Lin YL, Huang WL. Functioning and quality of life in patients with somatic symptom disorder: the association with comorbid depression. Compr Psychiatry. (2019) 90:88–94. doi: 10.1016/j.comppsych.2019.02.004
48. Jordan KM, Landis DA, Downey MC, Osterman SL, Thurm AE, Jason LA. Chronic fatigue syndrome in children and adolescents: a review. J Adolesc Health Off Publ Soc Adolesc Med. (1998) 22(1):4–18. doi: 10.1016/S1054-139X(97)00212-7
49. Barohn R, Dimachkie M, Jackson C. A pattern recognition approach to patients with a suspected myopathy. Neurol Clin. (2014) 32(3):569–93. doi: 10.1016/j.ncl.2014.04.008
50. Teoh H, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M. Inherited paediatric motor neuron disorders: beyond spinal muscular atrophy. Neural Plast. (2017) 2017:6509493. doi: 10.1155/2017/6509493
51. Owens S, Gutin B. Exercise intolerance. Pediatr in Rev. (2000) 21(1):6–9. doi: 10.1542/pir.21-1-6
52. Mancuso M, Angelini C, Bertini E, Carelli V, Comi GP, Minetti C, et al. Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian network of mitochondrial diseases. Neuromuscul Disord. (2012) 22:S226–9. doi: 10.1016/j.nmd.2012.10.012
53. Takahashi T, Yamada K, Kobayashi H, Hasegawa Y, Taketani T, Fukuda S, et al. Metabolic disease in 10 patients with sudden unexpected death in infancy or acute life-threatening events: sUDI and ALTE in metabolic disease. Pediatr Int. (2015) 57(3):348–53. doi: 10.1111/ped.12660
54. Owens J. Adolescent sleep working group, committee on adolescence. Insufficient sleep in adolescents and young adults: an update on causes and consequences. Pediatr. (2014) 134(3):e921–32. doi: 10.1542/peds.2014-1696
55. Cárdenas Villamil JP, Cavanzo Ramírez AI, García Manrique JG. El adolescente “cansado”: evaluación y manejo en al consulta de medicina familiar. Semergen. (2017) 44(2):1138–3593. doi: 10.1016/j.semerg.2017.01.009
56. Urbano G, Tablizo B, Moufarrej Y, Tablizo M, Chen M, Witmans M. The link between pediatric obstructive sleep apnea (OSA) and attention deficit hyperactivity disorder (ADHD). Children. (2021) 8(9):824. doi: 10.3390/children8090824
57. Schuler Iv CF, Montejo JM. Allergic rhinitis in children and adolescents. Immunol Allergy Clin North Am. (2021) 41(4):613–25. doi: 10.1016/j.iac.2021.07.010
58. Meltzer LJ, Pugliese CE. Sleep in young children with asthma and their parents. J Child Health Care. (2017) 21(3):301–11. doi: 10.1177/1367493517712064
59. Ramirez FD, Chen S, Langan SM, Prather AA, McCulloch CE, Kidd SA, et al. Association of atopic dermatitis with sleep quality in children. JAMA Pediatr. (2019) 173(5):e190025. doi: 10.1001/jamapediatrics.2019.0025
60. Cozzi G, Barbi E. Chronic school absenteeism as a diagnostic clue for paediatricians. J Paediatr Child Health. (2020) 56(2):191–3. doi: 10.1111/jpc.14689
61. Lemola S, Perkinson-Gloor N, Brand S, Dewald-Kaufmann JF, Grob A. Adolescents’ electronic Media use at night, sleep disturbance, and depressive symptoms in the smartphone age. J Youth Adolesc. (2015) 44(2):405–18. doi: 10.1007/s10964-014-0176-x
62. Kleppang AL, Steigen AM, Ma L, Søberg Finbråten H, Hagquist C. Electronic media use and symptoms of depression among adolescents in Norway. PLOS ONE. (2021) 16(7):e0254197. doi: 10.1371/journal.pone.0254197
63. Roach A. Supportive peer relationships and mental health in adolescence: an integrative review. Issues Ment Health Nurs. (2018) 39(9):723–37. doi: 10.1080/01612840.2018.1496498
64. Bakker RJ, van de Putte EM, Kuis W, Sinnema G. Risk factors for persistent fatigue with significant school absence in children and adolescents. Pediatr. (2009) 124(1):e89–95. doi: 10.1542/peds.2008-1260
65. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med. (1994) 121(12):953. doi: 10.7326/0003-4819-121-12-199412150-00009
66. Jason LA, Brown A, Clyne E, Bartgis L, Evans M, Brown M. Contrasting case definitions for chronic fatigue syndrome, myalgic encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis. Eval Health Prof. (2012) 35(3):280–304. doi: 10.1177/0163278711424281
67. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270(4):327–38. doi: 10.1111/j.1365-2796.2011.02428.x
68. Knight SJ, Politis J, Garnham C, Scheinberg A, Tollit MA. School functioning in adolescents with chronic fatigue syndrome. Front Pediatr. (2018) 6:302. doi: 10.3389/fped.2018.00302
69. Rangel L, Garralda ME, Levin M, Roberts H. The course of severe chronic fatigue syndrome in childhood. J R Soc Med. (2000) 93(3):129–34. doi: 10.1177/014107680009300306
70. Serafimova T, Loades M, Gaunt D, Crawley E. Who should we ask about mental health symptoms in adolescents with CFS/ME? Parent-child agreement on the revised children's Anxiety and depression scale. Clin Child Psychol Psychiatry. (2021) 26(2):367–80. doi: 10.1177/1359104521994880
71. Garralda ME, Rangel L. Annotation: chronic fatigue syndrome in children and adolescents. J Child Psychol Psychiatry. (2002) 43(2):169–76. doi: 10.1111/1469-7610.00010
72. Knight SJ, Scheinberg A, Harvey AR. Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. J Adolesc Health Off Publ Soc Adolesc Med. (2013) 53(2):154–65. doi: 10.1016/j.jadohealth.2013.03.009
73. Malas N, Ortiz-Aguayo R, Giles L, Ibeziako P. Pediatric somatic symptom disorders. Curr Psychiatry Rep. (2017) 19(2):11. doi: 10.1007/s11920-017-0760-3
74. Cozzi G, Minute M, Skabar A, Pirrone A, Mohamad J, Neri E, et al. Somatic symptom disorder was common in children and adolescents attending an emergency department complaining of pain. Acta Paediatr. (2017) 106(4):586–93. doi: 10.1111/apa.13741
75. Silber TJ, Pao M. Somatization disorders in children and adolescents. Pediatr Rev. (2003) 24(8):255–64. doi: 10.1542/pir.24-8-255
76. Tack M. Medically unexplained symptoms (MUS): faults and implications. Int J Environ Res Public Health. (2019) 16(7):1247. doi: 10.3390/ijerph16071247
77. Murray AM, Toussaint A, Althaus A, Löwe B. Barriers to the diagnosis of somatoform disorders in primary care: protocol for a systematic review of the current status. Syst Rev. (2013) 2:99. doi: 10.1186/2046-4053-2-99
78. De Sanctis V, Abbasciano V, Soliman AT, Soliman AT, Soliman N, Di Maio S, et al. The juvenile fibromyalgia syndrome (JFMS): a poorly defined disorder. Acta Bio Medica Atenei Parm. (2019) 90(1):134–48. doi: 10.23750/abm.v90i1.8141
79. Peri F, Nisticò D, Morabito G, Occhipinti A, Ventura A, Barbi E, et al. Somatic symptom disorder should be suspected in children with alleged chronic lyme disease. Eur J Pediatr. (2019) 178(8):1297–300. doi: 10.1007/s00431-019-03416-6
80. Jureidini JN, Shafer AT, Donald TG. “Munchausen by proxy syndrome”: not only pathological parenting but also problematic doctoring? Med J Aust. (2003) 178(3):130–2. doi: 10.5694/j.1326-5377.2003.tb05104.x
Keywords: fatigue, tiredness, fatigability, weakness, tired child, weariness, drowsiness
Citation: De Nardi L, Lanzetta MA, Ghirigato E, Barbi E and Gortani G (2022) Approach to the child with fatigue: A focus for the general pediatrician. Front. Pediatr. 10:1044170. doi: 10.3389/fped.2022.1044170
Received: 14 September 2022; Accepted: 16 November 2022;
Published: 2 December 2022.
Edited by:
Adamos A. Hadjipanayis, European University Cyprus, CyprusReviewed by:
Elisavet Efstathiou, European University Cyprus, CyprusLina Jankauskaite, Lithuanian University of Health Sciences, Lithuania
© 2022 De Nardi, Lanzetta, Ghirigato, Barbi and Gortani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Laura De Nardi laura.denardi1993@gmail.com
†These authors share last authorship
Specialty Section: This article was submitted to General Pediatrics and Pediatric Emergency Care, a section of the journal Frontiers in Pediatrics